On August 25, 2026, three 10% owners of Relay Therapeutics, Inc. (RLAY) executed significant stock sales, offloading a combined total of 18 million shares for approximately $349.20 million. Investment Advisers (Uk) Ltd Sb, Vision Fund (Aiv M2) L.P. Softbank, and Pauling (Cayman) Ltd Svf each sold 6 million shares at a price of $19.40 per share.
These transactions represent substantial divestitures by major stakeholders in Relay Therapeutics. While insider selling can be attributed to various factors such as portfolio diversification, tax obligations, or the need for personal liquidity, coordinated sales by multiple significant insiders may draw increased investor attention. The reported sales occurred amidst a period of general market activity.